In mitotic cells, SUN1 loses its interaction with N-terminal domain binding partners lamin A/C, emerin, and short nesprin-2 isoforms

In mitotic cells, SUN1 loses its interaction with N-terminal domain binding partners lamin A/C, emerin, and short nesprin-2 isoforms. connection between the SUN1 C-terminus and the KASH website of nesprin-2 is definitely managed during mitosis. Collectively, these data support a model whereby mitotic phosphorylation of SUN1 disrupts relationships with nucleoplasmic binding partners, promoting disassembly of the nuclear lamina and, potentially, its chromatin relationships. At the same time, our data add to an growing picture the core LINC complex plays an active part in NEBD. and ortholog, UNC-84, assisting their practical importance. In contrast, S333 is definitely poorly conserved and so its significance is definitely less obvious. To test whether Cdk1 and Plk1 are capable of phosphorylating SUN1, we performed in vitro kinase assays AS2521780 using purified MBP-tagged SUN1 protein fragments. We found that both Cdk1 and Plk1 phosphorylated a SUN1 fragment encompassing residues 1C217, but not residues 456C916, consistent with the presence of phosphorylation sites for both kinases with this N-terminal fragment (Fig.?2C-E). A fragment encompassing residues 1C362 was less well phosphorylated by Plk1, maybe because this fragment is not correctly folded, causing masking of the phosphorylation sites. Importantly, however, LC-MS/MS analysis of non-radiolabelled versions of both kinase-treated purified N-terminal SUN1 fragments confirmed phosphorylation of the same 3 sites previously recognized in vivo and, furthermore, shown that Cdk1 was capable of phosphorylation of S48 and S333, while Plk1 phosphorylated S138 (data not demonstrated). Cdk1 and Plk1 phosphorylate SUN1 in vivo To test the importance of Cdk1 and Plk1 for SUN1 phosphorylation in vivo, we treated mitotically-arrested HeLa cells with Cdk1 or Plk1 inhibitors and assessed whether the band-shift of endogenous SUN1 previously observed in mitotic components was lost. As demonstrated in Number?3A, the Cdk1 inhibitor roscovitine caused a significant reduction in the band-shift and this reduction was enhanced when combined inhibition of Cdk1 and Plk1 was performed. No reduction in the band-shift was observed in the presence of either Aurora A or MEK inhibitors. These data show that Cdk1 and Plk1 make a significant contribution to mitotic phosphorylation of SUN1. Of notice, migration of SUN1 within the gel did not return to the position observed in asynchronous cells, indicating that additional kinases may also play a role in SUN1 mitotic phosphorylation, or that it may undergo other Rabbit Polyclonal to USP6NL forms of covalent changes. Open in a separate window Number?3. SUN1 is definitely phosphorylated by Cdk1 and Plk1 in vivo. (A) HeLa cells were pre-arrested in S phase with AS2521780 AS2521780 aphidicolin, released and then caught in mitosis with nocodazole overnight. The indicated kinase inhibitors were added for the final 4 h of incubation and cell components were then subjected to immunoblotting alongside untreated asynchronous (As) samples using the indicated antibodies. Ros C roscovitine. (B) HeLa cells were transfected with the indicated wild-type (WT) or mutant myc-SUN1 constructs and components from either asynchronous or mitotic cells were prepared and immunoblotted as with A. (C) Purified casein, MBP, MBP-SUN1 (residues 1C217) and MBP-SUN1-S48A were subjected to in vitro phosphorylation by Cdk1 in the presence of [32P]–ATP. Samples were resolved by SDS-PAGE and dried gels analyzed by autoradiography to identify phosphorylated proteins. Parallel samples were prepared as above, except with the omission of radiolabelled ATP. Samples were immunoblotted using the polyclonal pS48-SUN1 antibody. The antibody recognized only phosphorylated wild-type SUN1. AS2521780 (D) Cells were transfected with either WT or S48A SUN1 mutant and cultivated asynchronously (As) or caught in mitosis (M) as explained inside a. Some samples were incubated with roscovitine (Ros) for the final 4 h, as indicated. Cell components were subjected to immunoprecipitation with myc antibodies and samples immunoblotted with myc or SUN1 pS48 antibodies. Initial lysates were probed with cyclin A antibodies to confirm cell cycle status. Molecular weights (kDa).